- Home
- JBGS vs OMCL Comparison
JBGS vs OMCL Comparison
Compare JBGS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBGS
- OMCL
- Stock Information
- Founded
- JBGS 2016
- OMCL 1992
- Country
- JBGS United States
- OMCL United States
- Employees
- JBGS N/A
- OMCL N/A
- Industry
- JBGS Real Estate Investment Trusts
- OMCL Computer Manufacturing
- Sector
- JBGS Real Estate
- OMCL Technology
- Exchange
- JBGS Nasdaq
- OMCL Nasdaq
- Market Cap
- JBGS 1.4B
- OMCL 1.3B
- IPO Year
- JBGS 2017
- OMCL 2001
- Fundamental
- Price
- JBGS $21.43
- OMCL $29.70
- Analyst Decision
- JBGS Sell
- OMCL Buy
- Analyst Count
- JBGS 2
- OMCL 6
- Target Price
- JBGS $16.00
- OMCL $45.33
- AVG Volume (30 Days)
- JBGS 850.6K
- OMCL 435.6K
- Earning Date
- JBGS 07-29-2025
- OMCL 07-31-2025
- Dividend Yield
- JBGS 3.64%
- OMCL N/A
- EPS Growth
- JBGS N/A
- OMCL N/A
- EPS
- JBGS N/A
- OMCL 0.45
- Revenue
- JBGS $512,802,000.00
- OMCL $1,135,755,000.00
- Revenue This Year
- JBGS N/A
- OMCL $3.84
- Revenue Next Year
- JBGS $2.20
- OMCL $3.98
- P/E Ratio
- JBGS N/A
- OMCL $65.38
- Revenue Growth
- JBGS N/A
- OMCL 3.00
- 52 Week Low
- JBGS $13.28
- OMCL $22.66
- 52 Week High
- JBGS $22.45
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- JBGS 81.23
- OMCL 57.42
- Support Level
- JBGS $18.79
- OMCL $27.77
- Resistance Level
- JBGS $19.60
- OMCL $28.91
- Average True Range (ATR)
- JBGS 0.69
- OMCL 0.96
- MACD
- JBGS 0.22
- OMCL 0.21
- Stochastic Oscillator
- JBGS 78.69
- OMCL 83.58
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.